💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Suven Life Sciences Limited is an India-based biopharmaceutical company, which is engaged in drug discovery and development of new chemical entities (NCEs) in central nervous system (CNS) disorders targeting unmet medical needs, globally. The Company's lead clinical-stage…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak business.
Suven Life Sciences is scored on the pharma / healthcare framework. Free cash flow is worth about -10.2% of its market value.
Book value itself has compounded 16%/yr — the hallmark of a genuine compounder. Return on equity is a weak -84.2%.
It trades at -20× earnings. The books come through clean — a forensic grade of B, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | -19.61 | — | — |
| P/B | 16.51 | 4.11 | worse |
| EV/EBITDA | — | 19.15 | — |
| ROE | -84.23 | 0.68 | worse |
| ROCE | -81.12 | 6.87 | worse |
| ROA | -75.45 | 1.26 | worse |
| Quick Ratio | 29.15 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 52.0 | 11.4 | 21.1% |
| Max Healthcare | 65.9 | 8.0 | 12.2% |
| Manipal Health Enterprises | 93.9 | 5.2 | 10.6% |
Negative CAGR — the top line has shrunk over this window. Growth is accelerating — latest year outpaced the prior year's rate.
4 of the 4 years shown had a loss — profitability is inconsistent. The latest year saw a -72% swing — check if it's a one-off or structural.
Negative ROE — the business is destroying shareholder value. Capital efficiency declining — ROE down 15pp.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play.
4 of 4 years had negative operating cash flow — profitability on paper may not translate to cash.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 34% sequentially — momentum is building. Wide quarterly swings (58% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 89% above earlier ones.
4 of 4 quarters loss-making — quarterly profitability is uneven. Profit fell 180% QoQ — one-quarter drops can be noise, but a pattern matters. Quarterly net margins are expanding (-1645% → -1151%) — profitability per rupee of revenue is improving.
P/E band unavailable — needs 5y of consistent EPS + price history.
Promoters hold 65.5% — heavily owner-operated with strong skin in the game. Promoters reduced 4.6pp over 4 quarters — watch whether this is planned divestment or pledge invocations.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.